November 21, 2025
1 min read

AstraZeneca boosts its presence in Maryland with $2B manufacturing investment

Maryland is becoming the home away from home for British drugmaker AstraZeneca. On Friday, the biopharma powerhouse upped its ante in the Old Line State, saying it will invest $2 billion to increase its manufacturing presence there.

Leave a Reply

Your email address will not be published.

Previous Story

Recalled Baby Formula Still on Store Shelves as Botulism Cases Rise

Next Story

What Science Says About How Much Our Food Choices Matter

Previous Story

Recalled Baby Formula Still on Store Shelves as Botulism Cases Rise

Next Story

What Science Says About How Much Our Food Choices Matter

Latest from Blog

ROFI Drives New Approach to Crop Nutrition

With input costs continuing to pressure farm budgets, some growers are making difficult decisions to reduce fertilizer application rates. While that strategy may ease upfront expenses, it is also accelerating a broader
Go toTop